Digest Network Come funziona
Network
/
Società
Si
Non verificato

Sironax USA, Inc.

Di cosa scriviamo

BiotecnologiaMedicina Salute Benessere

6 comunicati stampa

Guarda tutti i comunicati
11/05/2026
Biotecnologia
Sironax’s SARM1 Inhibitor SIR2501 Granted FDA Fast Track Designation in Chemotherapy-induced Peripheral Neuropathy (CIPN)
Fonte
Sironax USA, Inc.
Emittente
GLOBENEWSWIRE
1.00
0
22/04/2026
Biotecnologia
Sironax Announces Abstract on SARM1 Inhibitor SIR2501 Selected for Presentation at 2026 ASCO Annual Meeting
Fonte
Sironax USA, Inc.
Emittente
GLOBENEWSWIRE
1.00
0
26/03/2026
Biotecnologia
Sironax Appoints Clive Wang to Board of Directors
Fonte
Sironax USA, Inc.
Emittente
GLOBENEWSWIRE
1.00
0
20/03/2026
Biotecnologia
Sironax Announces Upcoming Poster Presentation on NAMPT Activation
Fonte
Sironax USA, Inc.
Emittente
GLOBENEWSWIRE
1.00
0
06/11/2025
Biotecnologia
Medicina Salute Benessere
Sironax Announces Three Abstracts Selected for Presentation at Neuroscience 2025
Fonte
Sironax USA, Inc.
Emittente
GLOBENEWSWIRE
1.00
0
22/10/2025
Biotecnologia
Medicina Salute Benessere
Sironax Announces Key Leadership Appointments to Advance Global Drug Discovery and Development
Fonte
Sironax USA, Inc.
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0